ArticleFrontiers in nutrition2025
Development of a high-throughput UHPLC-MS/MS multi-method for the analysis of mycotoxins in plant-based milk alternatives as the basis for risk assessment.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Editorial: Alternatives to traditional animal-based foods: production, characterization and comprehensive evaluation.Frontiers in nutrition · 2026Article
- Goals in Nutrition Science 2025-2030.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant-based alternatives to animal-based foods represent a rapidly growing market, as more and more consumers are willing to include these products into their daily diets. One particular segment is plant-based milk alternatives (PBMAs). Environmental and ethical concerns mainly drive this growing trend. However, the raw materials used in the production of PBMAs are susceptible to mycotoxin contamination, and currently, there are no regulatory limits for mycotoxins in PBMAs. Therefore, analyzing PBMAs to get more information about the mycotoxin contamination in these products is of great interest. To obtain more exposure data, we developed a QuEChERS (quick, easy, cheap, effective, rugged, and safe)-based multi-mycotoxin method to analyze 31
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.